Climb Bio, Inc. (CLYM) Tops Q1 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CLYM Hot Sheet
Join SI Premium – FREE
Climb Bio, Inc. (NASDAQ: CLYM) reported Q1 EPS of ($0.20), $0.09 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens Starts Oaktree Specialty Lending Corp (OCSL) at Market Perform
- Acres Commercial Realty Corp (ACR) PT Lowered to $17 at Citizens as Merger with ACC Announced
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
